Remedica CEO Dr Andrew Bird met with Subhash Jangala, First Secretary of the High Commission of India in Cyprus, recently.
Their discussion centred on enhancing business ties between Cypriot and Indian pharmaceutical companies, as well as upcoming initiatives by the government of India aimed at easing challenges for businesses engaged in bilateral transactions.
Commenting on the meeting Dr Bird said: “We are truly impressed by the Government of India’s long-term vision and its proactive, strategic approach to fostering a business-friendly environment, along with its steadfast efforts to position the country as a highly attractive destination for European businesses. We see particularly exciting potential in the pharmaceutical sector, where innovation, growth, and international partnerships are poised to drive significant progress.”
